With today's weather, we are currently in the midst of cold weather and rain. In this cold weather, we can easily catch ourselves with a common cold and fever, but there are other diseases that we can also be infected into our respiratory and circulatory systems. One of these diseases is Pneumonia, which is a disease in the Respiratory System. Knowing that this disease may infect us, we need to be careful with it! Anything can happen with the weather today and we need to keep a watchful eye on it!
Discussion:
Pneumonia is the inflammation of the lungs due to an infection, whether the infection would be bacterial or viral infection. This fills the air sacs with liquid or pus, which hardens the lungs and makes breathing difficult and transferring oxygen into the blood with Pneumonia active. This causes chest pains, confusion with their mental awareness, coughing, fatigue, and fever while Severe Pneumonia encounters high fever, vomiting, and diarrhea. To prevent this disease, the person with Pneumonia must have proper hygiene and a balance diet of eating the right amount of fruits and vegetables, along with exercising and getting enough sleep. When this disease is untreated, it becomes severe and, stated in a previous line, experiences with high fever with gastrointestinal symptoms, such as vomiting and diarrhea. As mentioned earlier, Pneumonia is caused by an infection into the lungs, whether it would be viral infection or bacterial infection, and the most common bacterial type that causes Pneumonia to become active is Streptococcus pneumoniae. Pneumonia cases are life-threatening because around 50,000 people die each year of this disease within the U.S. Although anyone of the age can be affected since pneumonia is more common in elderly people and often occurs when the immune system becomes weakened via a prior infection or another condition. Lastly, Pneumonia generally becomes more serious when it affects the following: older adults, infants and young children, those with chronic medical conditions, or those with weakened immune function.
Link to Economics:
With Economics, this creates the making and planning of decisions. The right choices we make are going to help in keeping our Respiratory and Circulatory System Diseases from becoming more severe, if it's left untreated. Pneumonia states itself as the single largest infectious cause of death in children worldwide. This disease carried the death 808 694 children in 2017, under the age of 5, this accounts 15% of all deaths of children under 5 years old. This disease can be prevented by immunization, adequate nutrition, and by addressing environmental factors. With this, the children with Pneumonia need the provided antibiotics but it's only a third of the children receives the antibiotics they need. Aside from that, children can be protected from this disease with simple interventions and treated with low-cost, low-tech medication and care.
The cost of antibiotic treatment for all children with pneumonia in 66 of the countdown to 2015 countries for maternal, newborn and child survival is estimated at around US$ 109 million per year. The price includes the antibiotics and diagnostics for pneumonia management. The management for pneumonia can be a little expensive for those who can't afford the antibiotics they need. With that being said, the Pneumococcal Conjugate Vaccine (PVC) had different evaluations to indicate the prize of the vaccine to be the main determinant of cost effectiveness. As the current prize is high (in the order of US 50 dollars per dose, which causes 2,619.15 Philippine Pesos per dose), the economic attractiveness of the universal PCV vaccination strategies hinges on the potential for price reductions and the willingness of decision makers to adopt a societal perspective.
References:
August 2, 2019, World Health Organization, "Pneumonia", retrieved from: https://www.who.int/news-room/fact-sheets/detail/pneumonia
De Graeve D, Beutels P, November 22, 2004, NCBI, "Economic Aspects of Pneumococcal Pneumonia: A Review of the Literature", retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/15250750
Melissa Conrad Stoppler, MD, August 17, 2018, Medicinenet, "Pneumonia Facts", retrieved from: https://www.medicinenet.com/pneumonia_facts/article.htm#pneumonia_facts
CREDITS:
Hanna Joan H. Alusin - Poster & Link to Economics
Aldrine Pacheco - Discussion
Aron B. Cazar - Introduction & Discussion
The cost of antibiotic treatment for all children with pneumonia in 66 of the countdown to 2015 countries for maternal, newborn and child survival is estimated at around US$ 109 million per year. The price includes the antibiotics and diagnostics for pneumonia management. The management for pneumonia can be a little expensive for those who can't afford the antibiotics they need. With that being said, the Pneumococcal Conjugate Vaccine (PVC) had different evaluations to indicate the prize of the vaccine to be the main determinant of cost effectiveness. As the current prize is high (in the order of US 50 dollars per dose, which causes 2,619.15 Philippine Pesos per dose), the economic attractiveness of the universal PCV vaccination strategies hinges on the potential for price reductions and the willingness of decision makers to adopt a societal perspective.
References:
August 2, 2019, World Health Organization, "Pneumonia", retrieved from: https://www.who.int/news-room/fact-sheets/detail/pneumonia
De Graeve D, Beutels P, November 22, 2004, NCBI, "Economic Aspects of Pneumococcal Pneumonia: A Review of the Literature", retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/15250750
Melissa Conrad Stoppler, MD, August 17, 2018, Medicinenet, "Pneumonia Facts", retrieved from: https://www.medicinenet.com/pneumonia_facts/article.htm#pneumonia_facts
CREDITS:
Hanna Joan H. Alusin - Poster & Link to Economics
Aldrine Pacheco - Discussion
Aron B. Cazar - Introduction & Discussion